Esra MUTLU, Özge KAYA, Arzu BİRİNCİ YİLDİRİM, Ayhan ÇETİNKAYA

Exosome Production, Isolation and Characterization from A549 Epithelial Carcinoma Cells

Exosomes are natural nanoparticles that special features have been started to be used for recent years in the treatment of cancer as a natural, homogeneous, nanosized, targeted vesicles (~ 50- 100 nm). They have high avidity (many conformational attachment) to attach onto targeted cancer cell surfaces. They are composed of bioactive double-layered lipid layers in which their original nature has the adhesive proteins interacting with the cancer cell membrane easily. In this study, the exosomes of non-small cell lung cancer A549 epithelial carcinoma cells were investigated for their potential to be the natural or synthetic drug carrier. Firstly, exosomes of A549 cell line were produced in exosome-free media. Immediately after, isolation of their exosomes were realized by using ultracentrifugation procedure. SEM image, particle size, zeta potential, exosomal RNA analysis and Protein Content by Bradford assays were performed. Findings (Size: 168 nm; zeta: -16mV) on the properties of A549 cell exosomes proved their potential to be used as the drug carrier for cancer cell therapy.

Keywords:

Exosome, ultracentrifugation, A549 Cell Line, miRNA,

PDF

___

1. G. Mignot, S. Roux, C. Thery, E. Ségura, L. Zitvogel, Prospects for exosomes in immunotherapy of cancer, J. Cell. Mol. Med., 10 (2006) 376-388.
2. M. Morello, V. Minciacchi, P. De Candia, J. Yang, E. Posadas, H. Kim, D. Griffiths, N. Bhowmick, L. Chung, P. Gandellini, Large oncosomes mediate intercellular transfer of functional microRNA, Cell cycle, 12 (2013) 3526-3536.
3. P. Vader, X. O. Breakefield, M. J. Wood, Extracellular vesicles: emerging targets for cancer therapy, Trends. Mol. Med., 20 (2014) 385-393.
4. M. S. Kim, M. J. Haney, Y. Zhao, V. Mahajan, I. Deygen, N. L. Klyachko, E. Inskoe, A. Piroyan, M. Sokolsky, O. Okolie, Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells, Nanomed-Nanotechnol., 12 (2016) 655-664.
5. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, M. J. Thun, Cancer statistics, 2008, CA: a cancer journal for clinicians, 58 (2008) 71-96.
6. R. Siegel, C. DeSantis, A. Jemal, Colorectal cancer statistics, 2014, CA: a cancer journal for clinicians, 64 (2014) 104-117.
7. C. Théry, M. Ostrowski, E. Segura, Membrane vesicles as conveyors of immune responses, Nat. Rev. Immunol., 9 (2009) 581.
8. J. Palma, S. C. Yaddanapudi, L. Pigati, M. A. Havens, S. Jeong, G. A. Weiner, K. M. E. Weimer, B. Stern, M. L. Hastings, D. M. Duelli, MicroRNAs are exported from malignant cells in customized particles, Nucleic Acids Res., 40 (2012) 9125-9138.
9. S. El-Andaloussi, Y. Lee, S. Lakhal-Littleton, J. Li, Y. Seow, C. Gardiner, L. Alvarez-Erviti, I. L. Sargent, M. J. Wood, Exosome-mediated delivery of siRNA in vitro and in vivo, Nat. Protoc., 7 (2012) 2112.
10. C. Lässer, M. Eldh, J. Lötvall, Isolation and characterization of RNA-containing exosomes, Jove-J. Vis. Exp., (2012).
11. M. M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72 (1976) 248-254.
12. W. Li, D. Mu, F. Tian, Y. Hu, T. Jiang, Y. Han, J. Chen, G. Han, X. Li, Exosomes derived from Rab27a‑overexpressing tumor cells elicit efficient induction of antitumor immunity, Mol. Med. Rep., 8 (2013) 1876-1882.
13. M. Wysoczynski,M. Z. Ratajczak, Lung cancer secreted microvesicles: underappreciated modulators of microenvironment in expanding tumors, Int. J. Cancer, 125 (2009) 1595-1603.
14. M. A. Morse, J. Garst, T. Osada, S. Khan, A. Hobeika, T. M. Clay, N. Valente, R. Shreeniwas, M. A. Sutton, A. Delcayre, A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer, J. Transl. Med., 3 (2005) 9.
15. Y.-T. Tang, Y.-Y. Huang, L. Zheng, S.-H. Qin, X.-P. Xu, T.-X. An, Y. Xu, Y.-S. Wu, X.-M. Hu, B.-H. Ping, Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum, Int. J. Mol. Med., 40 (2017) 834-844.